Kura Oncology, Inc. · NASDAQ:KURA
Armistice Capital, LLC reported a 7.46% stake in Kura Oncology, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC reported a 7.46% stake in Kura Oncology, Inc., 5,800,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 7.46%
- Shares
- 5,800,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 7.46% | 5,800,000 |
| Steven Boyd | 7.46% | 5,800,000 |
Source
Related
- Kura Oncology, Inc.
- Armistice Capital, LLC
- Kura Oncology, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Nov 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · Nov 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Form 4 · Ford Kathleen · Sep 29, 2026
- Form 4 · Leoni Mollie · Sep 29, 2026
- Form 4 · Powl Brian T. · Sep 29, 2026
- Form 4 · Bair Teresa Brophy · Sep 29, 2026
- Form 4 · Doyle Thomas James · Sep 29, 2026